Results 141 to 150 of about 4,696,118 (292)

Deep Sequencing of FLT3‐ITD Enables Response Evaluation and Post‐Treatment Monitoring in Childhood AML: An Exploratory Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background An internal tandem duplication in the gene encoding Fms‐like tyrosine kinase 3 (FLT3‐ITD) is associated with high relapse risk and poor prognosis in acute myeloid leukemia (AML) and plays a crucial role in treatment decisions. Measurable residual disease (MRD) analysis of FLT3‐ITD during and after treatment has shown prognostic ...
Sofie Johansson Alm, Bea Tornberg, Erik Delsing Malmberg, Henrik Hasle, Kristian Løvvik Juul‐Dam, Lars Palmqvist, Borhan R. Saeed, Giti Shah Barkhordar, Anastasia Soboli, Anna Staffas, Jonas Abrahamsson, Linda Fogelstrand   +11 more
wiley   +1 more source

Clinical outcome measurement [PDF]

British Journal of Psychiatry, 1999
openaire   +2 more sources

Claudin‐6 Protein Expression in Atypical Teratoid/Rhabdoid Tumors Is Strongly Enriched in the Molecular Subgroup AT/RT‐TYR

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Claudin‐6 has emerged as a promising immunotherapeutic target, yet protein‐level data in atypical teratoid/rhabdoid tumors (AT/RTs) have been inconsistent. We analyzed 36 well‐characterized AT/RT samples and found membranous claudin‐6 protein expression in 58% of cases, with striking enrichment in the molecular subgroup AT/RT‐TYR (100%) and ...
Victoria E. Fincke, Christian Thomas, Michael C. Frühwald, Pascal D. Johann, Martin Hasselblatt   +4 more
wiley   +1 more source

Persistent Cough: Changes in Prevalence, Impact, and Beliefs From 2006–2015 in Italy

European Medical Journal, 2019
Background: Persistent cough is one of the most common conditions affecting quality of life. The aim of this study was to assess people’s beliefs regarding the impact of, and changes in the prevalence of, persistent cough in the Italian general ...
Roberto Walter Dal Negro, Massimiliano Povero,, Alessandro Zanasi, Paola Turco   +3 more
doaj  

Time Toxicity in Wilms Tumor: Quantifying the Burden of Healthcare Interaction in the First Year After Diagnosis

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Wilms tumor (WT) treatment imposes a significant time burden on patients and their families. Time toxicity is a patient‐centered metric that quantifies the burden of healthcare interaction. We sought to define time toxicity in the first year after diagnosis of WT and hypothesized that it would increase as tumor stage and treatment ...
Caleb Q. Ashbrook, Veerain Gupta, Nicholas J. Clark, Vijay Rings, Lauren E. Corona, Douglass B. Clayton, Daniel J. Benedetti   +6 more
wiley   +1 more source

CLINICAL OUTCOMES [PDF]

Japanese Journal of Clinical Oncology, 2011
Y. Horikawa, N. Tsuchiya, K. Yuasa, S. Narita, M. Saito, K. Takayama, T. Nara, H. Tsuruta, T. Obara, K. Numakura, S. Satoh, T. Habuchi, X. Hu, J. Guo, Z. Lin, L. Sun, Z. Xu, C. Cang, G. Wang, T. Kanda, K. Sakamoto, A. Matsuki, R. Ohashi, S. Hirota, Y. Fujimori, Y. Matsuda, K. Yajima, S. Kosugi, K. Hatakeyama, K. Kitahara, M. Watanabe, S. Nakazono, N. Wada, H. Kakizaki, J. Li, F. J. Gong, P. N. Sun, L. Shen, Q. Li, N. Li, M. Qiu, J. Liu, C. Yi, D. Luo, Z. Li, H. Gou, Y. Yang, D. Cao, Y. Shen, X. Wang, F. Xu, F. Bi, Q. Li, X. Zhang, N. Li, W. Wei, H. Y. Luo, Z. Q. Wang, F. H. Wang, M. Z. Qiu, K. Y. Teng, D. Y. Ruan, Y. J. He, Y. H. Li, R. H. Xu, S. Matsusaka, N. Mizunuma, M. Suenaga, E. Shinozaki, Y. Mishima, Y. Terui, K. Hatake, E. Nara, M. Kodaira, Y. Mishima, M. Yokoyama, T. Saotome, Y. Terui, S. Takahashi, K. Hatake, N. Nishimura, K. Nakano, M. Kodaira, K. Ueda, S. Yamada, Y. Mishima, M. Yokoyama, T. Saotome, S. Takahashi, Y. Terui, K. Hatake, M. Nozawa, Y. Mochida, K. Nishigaki, S. Nagae, H. Uemura, S. Y. Oh, C. Y. Jeong, S. C. Hong, W. S. Lee, H. G. Kim, G.-W. Lee, I. G. Hwang, J. S. Jang, H.-C. Kwon, J. H. Kang, M. Ozaka, M. Ogura, S. Matsusaka, E. Shinozaki, M. Suenaga, K. Chin, N. Mizunuma, K. Hatake, P. F. Pua, D. Ganzon, V. Chan, K. Sailaja, S. Vishnupriya, D. Raghunadharao, G. Markandeya, P. R. K. Reddy, P. Reddanna, D. Praveen, K. Sakamoto, T. Kanda, A. Matsuki, T. Takano, T. Hanyu, K. Yajima, S. Kosugi, S. Hirota, K. Hatakeyama, T. Shigekawa, N. Ijichi, S. Takayama, H. Tsuda, K. Ikeda, K. Horie, A. Osaki, T. Saeki, S. Inoue, J. Subhashini, B. Rajesh, I. Rajesh, P. Ravindran, K. Takagi, K. Chin, M. Oba, Y. Kuboki, T. Ichimura, M. Oto, Y. Kawazoe, T. Watanabe, M. Ozaka, M. Ogura, M. Suenaga, E. Shinozaki, S. Matsusaka, N. Mizunuma, K. Hatake, K. Ueda, T. Saotome, S. Yamada, N. Nishimura, E. Nara, K. Nakano, M. Kodaira, A. Katsube, Y. Mishima, Y. Terui, M. Yokoyama, S. Takahashi, K. Hatake, X. Yao, Q. Yang, C. Li, L. Diao, X. Chen, Z. Yu, W. Zuo, Y. Wang, Y. He, X. Zhang, S. Cai, Z. Wang, J. Xu, W. Zhan, Y. F. Zhang, M. Misumi, H. Takeuchi, N. Nakamiya, T. Shigekawa, K. Matsuura, N. Fujiuchi, A. Osaki, T. Saeki   +196 more
openaire   +1 more source

Emapalumab for Immune Effector Cell‐Associated Hemophagocytic Lymphohistiocytosis‐Like Syndrome Following CD19‐Directed CAR‐T in Two Patients With B‐ALL: Clinical and Biomarker Correlates

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Immune effector cell‐associated hemophagocytic lymphohistiocytosis‐like syndrome (IEC‐HS) is a life‐threatening hyperinflammatory toxicity distinct from cytokine release syndrome (CRS) and neurotoxicity following chimeric antigen receptor T‐cell (CAR‐T) therapy. In a single‐institution retrospective cohort of pediatric and young adult patients
Thomas J. Galletta, Jeremy D. Rubinstein, Christopher E. Dandoy, Ruby Khoury, Angela Faulhaber, Christine L. Phillips, Christa Krupski   +6 more
wiley   +1 more source

Increased Risk of Sarcomas in Children With Congenital Anomalies: Findings From the Genetic Overlap Between Anomalies and Cancer in Kids (GOBACK) Registry Linkage Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Pediatric sarcomas are a heterogeneous group of tumors that contribute disproportionately to cancer mortality in children. Although congenital anomalies are among the strongest known risk factors for childhood cancer, the risk of specific sarcoma subtypes among affected individuals has not yet been thoroughly evaluated. Procedure We
Russ Wolters, Ji Yun Tark, Tiffany M. Chambers, Tania A. Desrosiers, Michael E. Scheurer, Charles Shumate, Wendy N. Nembhard, Mahsa M. Yazdy, Eirini Nestoridi, Amanda E. Janitz, Jean Paul Tanner, Russell S. Kirby, Jason L. Salemi, Yao Yu, Chad D. Huff, Sharon E. Plon, Philip J. Lupo, Jeremy M. Schraw   +17 more
wiley   +1 more source

Supporting Survivor‐Centered Care Through Digital Health Integration

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Survivors of childhood cancer face barriers to receiving guideline‐based, long‐term follow‐up care. Two digital tools, Passport for Care (PFC) and Cancer SurvivorLink (SurvivorLink), address complementary gaps by enabling tailored survivorship care plan (SCP) generation, updating, storage, and sharing.
Jordan G. Marchak, Rebecca Williamson‐Lewis, Michael O'Connor, Michael Palgon, Yu‐Ra Kim, Michael Schuckenbrock, Paula Edwards, Abraham Mendoza, Anthony Adams, Brian Arriaga‐Solis, Justin Parker, Harry Tinoco‐Giraldo, Jason King, C. Michael Fordis, Karen E. Effinger, Maria Monica Gramatges   +15 more
wiley   +1 more source